Complementary, alternative, integrative and dietary therapies for children with Crohn's disease - A systematic review

M Schwermer1, K Fetz2, A Längler1

  • 1Department of Pediatrics, Gemeinschaftskrankenhaus Herdecke, Germany, Professorship for Integrative Pediatrics, Institute for Integrative Medicine, Witten/Herdecke University, Germany.

Insights

Dietary interventions like enteral nutrition and omega-3 fatty acids show promise as effective alternatives to corticosteroids for pediatric Crohn's disease, reducing side effects in children. Further research is needed for complementary therapies.

Area of Science:

  • Pediatric Gastroenterology
  • Clinical Nutrition
  • Inflammatory Bowel Disease Research

Background:

  • Pediatric Crohn's disease (CD) presents chronic challenges, including psychological stress and growth-impeding corticosteroid side effects.
  • Alternative therapies are sought to mitigate treatment burdens in pediatric CD patients.
  • Elemental and other dietary interventions are recognized options for managing pediatric CD.

Purpose of the Study:

  • To systematically review controlled studies on dietary therapies for pediatric Crohn's disease.
  • To assess the efficacy and safety of alternative treatments compared to standard therapies.
  • To identify research gaps in complementary and alternative medicine (CAM) for pediatric CD.

Main Methods:

  • Systematic literature search of multiple databases (Cochrane, EMBASE, PubMed, etc.) from inception to December 2019.
  • Inclusion of randomized controlled trials (RCTs) and controlled trials evaluating dietary interventions.
  • Analysis of studies on elemental, semi-elemental, polymeric diets, whole protein formulas, and ω-3 fatty acids.

Main Results:

  • Seven studies met criteria, including six RCTs and one controlled trial.
  • Dietary therapies (enteral diets, ω-3 fatty acids) demonstrated efficacy comparable or superior to corticosteroids in pediatric CD.
  • No controlled studies were found for complementary, alternative, and integrative medicine (CAIM) approaches.

Conclusions:

  • Enteral diets and ω-3 fatty acid supplementation represent a viable, potentially less aggressive alternative to corticosteroids for pediatric Crohn's disease.
  • Current evidence on CAIM for pediatric CD is lacking, necessitating further clinical trials.
  • More research is required to establish the risks and benefits of CAIM in pediatric CD management.

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
532
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
359
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
332
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
318
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
732
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
664